Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study-Reference-Cited by-同舟云学术

Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study

Published:2020-05 Issue: Volume:301 Page:1-7
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Casula Manuela,Olmastroni Elena,Galimberti Federica,Tragni Elena,Corrao Giovanni,Scotti Lorenza,Catapano Alberico L.

Funder

Amgen

AstraZeneca

Lilly

Genzyme

Merck

MSD

Pfizer

Rottapharm

Regeneron

Sigma-Tau

AIFA

Ministry of Education, University and Research

MIUR

Novartis

GSK

Roche

BMS

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference60 articles.

1. Correlation between osteoporosis and cardiovascular disease;Sprini;Clin. Case. Min. Bone Metabol. Off. J Italian Soc. Osteoporos., Min. Metabol., Skeletal Dis.,2014

2. The link between osteoporosis and cardiovascular disease;Farhat;Clin. Case. Min. Bone Metabol. Off. J Italian Soc. Osteoporos., Min. Metabol., Skeletal Dis.,2008

3. Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies;Caffarelli;Clin. Interv. Aging,2017

4. Vascular effects of bisphosphonates-a systematic review;Santos;Clin. Med. Insights Endocrinol. Diabetes,2012

5. Atherosclerotic calcification: relation to developmental osteogenesis;Bostrom;Am. J. Cardiol.,1995

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials;Drug Safety;2024-09-03

2. Cardiovascular safety of zoledronic acid in the treatment of primary osteoporosis: A meta-analysis and systematic review;Seminars in Arthritis and Rheumatism;2024-02

3. The State of Use and Utility of Negative Controls in Pharmacoepidemiologic Studies;American Journal of Epidemiology;2023-10-17

4. Antiosteoporosis medications and cardiovascular disease: a population-based nationwide nested case–control study;Frontiers in Pharmacology;2023-10-10

5. Association between bisphosphonate use and stroke risk: a meta-analysis;Osteoporosis International;2023-05-30